DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Herceptin (Trastuzumab) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (120)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Herceptin (Trastuzumab) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 120   Next >>

Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-08-21

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia Cytomegaloviral

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: last dose prior to sae: 02/jul/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Herceptin
    Dosage: last dose prior to sae: 18/jun/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Lapatinib
    Dosage: last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-06-14

Paclitaxel
    Dosage: last dose prior to sae: 02/jul/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09



Possible Herceptin side effects in female

Reported by a physician from Bosnia and Herzegowina on 2012-08-20

Patient: female, weighing 95.0 kg (209.0 pounds)

Reactions: Gastrointestinal Haemorrhage

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in 63 year old female

Reported by a physician from United Kingdom on 2012-08-20

Patient: 63 year old female, weighing 100.0 kg (220.0 pounds)

Reactions: Myalgia, Multi-Organ Failure, Malaise, Neutropenic Sepsis, Pain, Necrotising Fasciitis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Indication: Breast Cancer Stage I
    Start date: 2010-04-30
    End date: 2010-05-24

Docetaxel
    Dosage: dose reduced,third dose not given.

Herceptin
    Indication: Breast Cancer Stage I

Other drugs received by patient: Cyclophosphamide; Fluorouracil; Dexamethasone; Epirubicin; Tinzaparin



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-17

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Haemorrhage Intracranial, Sepsis, Hypotension, Pneumonia Streptococcal, Failure To Thrive, Acute Respiratory Failure, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Other drugs received by patient: Naproxen; Dexamethasone; Zometa; Dextrose; Ativan; Diphenhydramine HCL; Neulasta; Lortab; Robaxin; Fosphenytoin Sodium; Ciprofloxacin; Magnesium Sulfate; Lasix; Ferrous Sulfate TAB; Remeron; Artificial Tears; Amlodipine Besylate; Benadryl; Hydrocodone; Celexa; Acetaminophen; Lorazepam; Phenergan HCL; Potassium Chloride; Hydrocodone Bitartrate + Acetaminophen; Protonix; Aloxi; Mineral OIL; Insulin Aspart; Morphine Sulfate; Zofran; Cocaine; Udderly Smooth Cream



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-16

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Sepsis, Pneumonia Streptococcal, Hypotension, Haemorrhage Intracranial, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Other drugs received by patient: Dexamethasone; Protonix; Zosyn; Insulin Aspart; Udderly Smooth Cream; Benadryl; Naproxen; Celexa; Aloxi; Diphenhydramine HCL; Zometa; Phenergan HCL; Acetaminophen; Fosphenytoin Sodium; Lortab; Lorazepam; Cocaine; Potassium Chloride; Ceftriaxone; Mineral OIL; Lasix; Levophed; Ferrous Sulfate TAB; Ciprofloxacin; Dextrose; Vancomycin HCL; Ativan; Neulasta; Robaxin; Artificial Tears; Hydrocodone; Remeron; Zofran; Hydrocodone Bitartrate + Acetaminophen; Magnesium Sulfate; Phenytoin Sodium



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-15

Patient: female, weighing 57.6 kg (126.7 pounds)

Reactions: Abdominal Pain, Diarrhoea, Disseminated Intravascular Coagulation, Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: permanently discontinued
    End date: 2012-05-25

Carboplatin
    Dosage: temporarily discontinued
    Indication: Breast Cancer
    Start date: 2012-04-13
    End date: 2012-05-04

Docetaxel
    Dosage: permanently discontinued
    End date: 2012-05-25

Docetaxel
    Dosage: permanently discontinued
    Indication: Breast Cancer
    Start date: 2012-04-13
    End date: 2012-05-04

Herceptin
    Dosage: permanently discontinued
    End date: 2012-05-25

Herceptin
    Dosage: maintanance dose, temporarily interrupted
    End date: 2012-05-04

Herceptin
    Dosage: loading dose, permanently discontinued
    Indication: Breast Cancer
    Start date: 2012-04-13

Pertuzumab
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-13
    End date: 2012-05-25

Other drugs received by patient: Clindamycin; Lovaza; Tylenol; Zofran



Possible Herceptin side effects in 63 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-15

Patient: 63 year old female, weighing 100.0 kg (220.0 pounds)

Reactions: Myalgia, Multi-Organ Failure, Pain, Neutropenic Sepsis, Necrotising Fasciitis, Mobility Decreased

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: 100 mg/m2, unk
    Indication: Breast Cancer Stage I
    Start date: 2010-04-30

Docetaxel
    Dosage: 75 mg/m2, unk
    End date: 2010-05-25

Herceptin
    Indication: Breast Cancer Stage I
    Start date: 2010-05-21

Other drugs received by patient: Tinzaparin; Epirubicin; Dexamethasone; Fluorouracil; Cyclophosphamide



Possible Herceptin side effects in 74 year old female

Reported by a physician from United States on 2012-08-15

Patient: 74 year old female, weighing 72.0 kg (158.4 pounds)

Reactions: Myelodysplastic Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 600 mg/m2 iv over 30 min, on day 1 q21 dayx 4, date of last drug taken prior to onset of ae:18/jun/2
    Indication: Breast Cancer
    Start date: 2002-04-08

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2 intravenous push on day 1 every21 days x 4,date of last drug taken prior to onset of ae:18/
    Indication: Breast Cancer
    Start date: 2002-04-08

Herceptin
    Dosage: 4mg/kg over 90min (loading dose) on day1 of wk13 only,2mg/kg over 30 min (maintenance dose) qwk for
    Indication: Breast Cancer
    Start date: 2002-04-08

Paclitaxel
    Dosage: 175 mg/m2 over 3 hr q 21d starting day 1 of wk 13x 4, date of last drug taken prior to onset of ae:1
    Indication: Breast Cancer
    Start date: 2002-04-08



Possible Herceptin side effects in 58 year old female

Reported by a physician from China on 2012-08-14

Patient: 58 year old female

Reactions: Dyspnoea, Pleural Effusion, Pulmonary Embolism, Disease Progression

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13

Patient: female, weighing 71.3 kg (156.8 pounds)

Reactions: Contusion, Gingival Bleeding, Petechiae

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-08-10

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia Cytomegaloviral

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: last dose prior to sae: 02/jul/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Herceptin
    Dosage: last dose prior to sae: 18/jun/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Lapatinib
    Dosage: last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-05-07

Paclitaxel
    Dosage: last dose prior to sae: 02/jul/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-08-06

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia Viral, Interstitial Lung Disease, Respiratory Failure, Multi-Organ Disorder, Pulmonary Mycosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Herceptin
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Lapatinib
    Dosage: 750 milligram daily;
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-05-07

Paclitaxel
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Other drugs received by patient: Acetaminophen; Thyranojod



Possible Herceptin side effects in female

Reported by a physician from Philippines on 2012-08-03

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Febrile Neutropenia, Duodenal Ulcer, Hepatic Failure, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: dose level:100 mg/m2; last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Mucosta; Fluconazole; Acetaminophen; Tinzaparin; Tranexamic Acid; Omeprazole; Ciprofloxacin; Vitamin K TAB



Possible Herceptin side effects in 51 year old female

Reported by a consumer/non-health professional from Russian Federation on 2012-07-31

Patient: 51 year old female

Reactions: Product Counterfeit, Disease Progression

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-07-26

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia Viral, Interstitial Lung Disease, Respiratory Failure, Pyrexia, Multi-Organ Disorder, Pulmonary Mycosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Herceptin
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Lapatinib
    Dosage: 750 milligram;
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-05-07

Paclitaxel
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Other drugs received by patient: Thyranojod; Acetaminophen



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-07-19

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Pneumonia Streptococcal, Sepsis, Haemorrhage Intracranial, Hypotension, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic



Possible Herceptin side effects in female

Reported by a physician from China on 2012-07-17

Patient: female, weighing 63.0 kg (138.6 pounds)

Reactions: Suicide Attempt, Neutropenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Avastin
    Dosage: last dose: 21 jul 2010
    Indication: Breast Cancer
    Start date: 2010-03-16
    End date: 2010-08-30

Carboplatin
    Dosage: last dose: 30 jun 2010
    Indication: Breast Cancer
    Start date: 2010-03-16

Clonazepam
    Indication: Product Used FOR Unknown Indication

Docetaxel
    Dosage: last dose: 30 jun 2010
    Indication: Breast Cancer
    Start date: 2010-03-16

Herceptin
    Dosage: last dose: 21 jul 2010
    Indication: Breast Cancer
    Start date: 2010-03-16
    End date: 2010-08-30



Possible Herceptin side effects in female

Reported by a physician from United States on 2012-07-17

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Hypotension, Sepsis, Haemorrhage Intracranial, Pneumonia Streptococcal, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-09

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Hypotension, Haemorrhage Intracranial, Sepsis, Pneumonia Streptococcal, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Japan on 2012-07-06

Patient: female, weighing 65.0 kg (143.0 pounds)

Reactions: Cardiac Failure, Cardiac Arrest, Cardiogenic Shock

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2007-03-27
    End date: 2007-07-10

Epirubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2007-03-27
    End date: 2007-07-10

Fluorouracil
    Indication: Breast Cancer
    Start date: 2007-03-27
    End date: 2007-07-10

Herceptin
    Indication: Breast Cancer
    Start date: 2007-08-10
    End date: 2007-08-10

Herceptin
    Dosage: dosage was decreased
    Start date: 2007-08-17
    End date: 2009-09-14

Other drugs received by patient: Nolvadex; Levothyroxine Sodium; Trichlormethiazide



Possible Herceptin side effects in female

Reported by a physician from Japan on 2012-07-05

Patient: female, weighing 65.0 kg (143.0 pounds)

Reactions: Cardiac Failure, Cardiogenic Shock, Cardiac Arrest

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2007-03-27
    End date: 2007-07-10

Epirubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2007-03-27
    End date: 2007-07-10

Fluorouracil
    Indication: Breast Cancer
    Start date: 2007-03-27
    End date: 2007-07-10

Herceptin
    Indication: Breast Cancer
    Start date: 2007-08-10
    End date: 2007-08-10

Herceptin
    Dosage: dosage was decreased
    Start date: 2007-08-17
    End date: 2009-09-14

Other drugs received by patient: Nolvadex; Levothyroxine Sodium; Trichlormethiazide



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-06-22

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Pneumonia Streptococcal, Haemorrhage Intracranial, Hypotension, Sepsis, Failure To Thrive, Acute Respiratory Failure, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Philippines on 2012-06-15

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Duodenal Ulcer, Hepatic Failure, Febrile Neutropenia, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: dose level:100 mg/m2; last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Acetaminophen; Vitamin K TAB; Fluconazole; Mucosta; Ciproflaxacin; Omeprazole; Tranexamic Acid; Tinzaparin



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-06-13

Patient: female, weighing 80.0 kg (176.0 pounds)

Reactions: Cardiac Failure, Atrioventricular Block, Cardiomyopathy

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from France on 2012-06-12

Patient: female, weighing 63.0 kg (138.6 pounds)

Reactions: Subdural Haematoma, Cardiac Failure

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Aspirin
    Indication: Cardiac Failure

Herceptin
    Indication: Breast Cancer
    End date: 2012-02-08

Herceptin
    Start date: 2012-04-06



Possible Herceptin side effects in 55 year old male

Reported by a individual with unspecified qualification from Brazil on 2012-06-12

Patient: 55 year old male

Reactions: Death, Vomiting, Nausea, Peripheral Sensory Neuropathy, Disease Progression

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Herceptin
    End date: 2011-04-30

Herceptin
    Indication: Gastric Cancer
    Start date: 2010-11-15

Other drugs received by patient: Fluorouracil; Fluorouracil; Leucovorin Calcium; Oxaliplatin



Possible Herceptin side effects in female

Reported by a physician from Philippines on 2012-06-08

Patient: female, weighing 52.5 kg (115.5 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Hepatic Failure, Duodenal Ulcer, Febrile Neutropenia, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Ciprofloxacin; Acetaminophen; Mucosta; Omeprazole; Fluconazole; Vitamin K TAB; Tinzaparin; Tranexamic Acid



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Philippines on 2012-06-08

Patient: female, weighing 52.5 kg (115.5 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Duodenal Ulcer, Hepatic Failure, Febrile Neutropenia, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Ciprofloxacin; Fluconazole; Tinzaparin; Acetaminophen; Omeprazole; Mucosta; Tranexamic Acid; Vitamin K TAB



Possible Herceptin side effects in female

Reported by a physician from Philippines on 2012-06-07

Patient: female, weighing 52.5 kg (115.5 pounds)

Reactions: Gastrointestinal Ulcer, Pneumonia, Cardio-Respiratory Arrest, Hepatic Failure, Febrile Neutropenia, Duodenal Ulcer, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Omeprazole; Ciprofloxacin; Fluconazole; Acetaminophen; Tinzaparin; Vitamin K TAB; Mucosta; Tranexamic Acid



Possible Herceptin side effects in 61 year old female

Reported by a physician from United States on 2012-06-07

Patient: 61 year old female

Reactions: Acute Lymphocytic Leukaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Adriamycin PFS
    Indication: Breast Cancer
    Start date: 2000-01-01

Cytoxan
    Indication: Breast Cancer
    Start date: 2000-01-01

Herceptin
    Indication: Breast Cancer
    Start date: 2000-01-01
    End date: 2002-01-01

Taxol
    Indication: Breast Cancer
    Start date: 2000-01-01
    End date: 2002-01-01



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014